Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
NCT ID: NCT02125825
Last Updated: 2016-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2014-07-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment
NCT02509325
Validation of DaTscan for Detection of Parkinson Disease Related Disorders
NCT02138682
Udall Project 2 Aim 2A&C
NCT05656586
Battery-preserving Stimulation Patterns for Deep Brain Stimulation
NCT02569021
Automated Deep Brain Stimulation Programming Using Functional Mapping
NCT02765282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease on levodopa
Individuals with Parkinson's disease who are taking levodopa to treat motor symptoms
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical history of levodopa-induced dyskinesia
* 21 Years of age or older
* Stage 2 - 4 OFF-medication on the Hoehn and Yahr scale
Exclusion Criteria
* Severe tremor unaffected by levodopa
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Rochester
OTHER
Johns Hopkins University
OTHER
Great Lakes NeuroTechnologies Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Medical Center
Baltimore, Maryland, United States
University of Rochester Medical Center
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KinesiaDPhaseIIYear1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.